New Directions in Influenza Management: The Pharmacist’s Guide to Patient Identification, Testing, and Antiviral Use
Hosted by the Virginia Pharmacists Association, supported by an educational grant from Genentech, a member of the Roche Group

Differentiating influenza from other viruses, and treating high-risk patients in a timely manner to avoid overburdening the healthcare system, has never been more relevant. Join us for a timely, expert-led CPE program that will marry the current data and guideline recommendations on influenza testing, diagnosis, and antiviral treatment with engaging whiteboard animation case studies, so you are prepared to apply the latest updates in influenza to clinical practice now.

Faculty Presenter
Jason E. Bowling, MD
Associate Professor, Department of Medicine
Division of Infectious Diseases
UT Health San Antonio, Texas

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

• Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
• Assess the need for influenza treatment based on patient signs, symptoms, and accurate interpretation of appropriate diagnostic tests when necessary
• Recommend individualized antiviral treatment plans for patients with, or at risk for, influenza in accordance with the latest evidence

Register Now!